AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 APR 16 - (NewsRx.com & NewsRx.net) -- A technology developed to enhance images from space and locate submarines from the air is being used to screen for the early stages of cervical cancer in women. The first U.S. clinical trials have begun at Tripler Army Medical Center.
The HyperSpectral Diagnostic Imaging equipment uses a seven-second noninvasive test to take a picture of the cervix, said Nicholas J. Susner, president and chief executive officer of Honolulu-based Science & Technology International (STI).
The instrument sees nearly 300 separate colors, creating a picture of the cervix containing detail not visible to the naked eye or through a microscope. Because precancerous and cancer cells have a larger blood flow than normal tissue, those cells appear as different colors.
Cervical cancer strikes 12,900 American women each year and kills 4400. It usually grows slowly, so regular Pap smears can catch it early - often, when cells are just beginning to turn cancerous. Early detection can help doctors cure or even prevent cervical cancer.
Susner and Dr. Katarina Svanberg, chief oncologist at the Lund University Hospital and Medical School in Sweden, told the House Health Committee that cervical cancer trials have been completed in Lithuania and were scheduled to resume at Tripler using the diagnostic imaging ...
Source: HighBeam Research, Trials begin on high-tech screening test.(Brief Article)